Yahoo Malaysia Web Search

Search results

  1. Samsung Biologics is a fully integrated CDMO that offers development, manufacturing, and quality services for biologics and antibody-drug conjugates. Learn more about their innovative solutions, upcoming events, and company news.

    • About Us

      Samsung Biologics is a fully integrated, end-to-end CDMO...

    • Our Services

      Samsung Biologics offers customized solutions to optimize...

    • Careers

      Samsung Biologics. Who we want. Talent with vision and goals...

    • Sustainability

      Samsung Biologics is pursuing its mission to create a better...

    • Investors

      Samsung Biologics is committed to delivering solid financial...

    • Newsroom

      Samsung Biologics to attend BIOPLUS•INTERPHEX KOREA 2024...

    • Manufacturing Services

      Samsung Biologics is a reliable partner for seamless tech...

    • Quality

      Samsung Biologics is committed to the following: We strive...

  2. Samsung Biologics Co., Ltd. is a South Korean biotechnology company headquartered in Songdo, Incheon, South Korea. The biotech division of Samsung Group, it provides contract development and manufacturing (CDMO) services to the biopharmaceutical industry.

  3. Mar 31, 2023 · Samsung Biologics offers end-to-end solutions from cell line development to final aseptic fill/finish for biopharmaceutical products. Learn about its vision, mission, and values as a trusted partner for Better Life for humanity.

  4. Samsung Biologics is a fully integrated CDMO offering state-of-the-art contract development and manufacturing services.

  5. Jul 3, 2024 · Samsung Biologics announced July 2 that it has signed a $1.06 billion contract with a U.S.-based pharmaceutical company for the contract manufacturing of biopharmaceuticals. This is the largest contract ever secured by a South Korean biotech company and represents 42% of Samsung Biologics’ total orders from last year.

  6. Mar 21, 2022 · Samsung Biologics, the biopharmaceutical unit of South Koreas Samsung Group, is seeking to build its first plants in the US and Europe as it rebalances its global supply chains...

  7. Jul 4, 2023 · South Korea's Samsung Biologics announced on Tuesday two deals with Pfizer worth a combined $897 million to manufacture products for the U.S. pharmaceutical giant.